Telerad Group Unveils AI-Based Solution for Pulmonary Embolism Detection

PE Assist is designed to assist radiologists in identifying and communicating suspected positive findings of pulmonary embolism in chest CT angiograms. This facilitates quicker intervention, potentially saving lives.

Telerad Group has introduced an AI-based solution aimed at transforming pulmonary embolism detection, ultimately enhancing radiologists' efficiency and accuracy worldwide. The advanced technology, named Pulmonary Embolism Assist (PE Assist), targets the critical medical condition affecting millions globally.

The unveiling took place at the Radiological Society of North America (RSNA) event held from November 26-29, 2023. PE Assist is poised to redefine the global landscape of medical diagnostics, specifically in the analysis of chest and thoraco-abdominal Computed Tomography angiography.

Pulmonary embolism (PE) is a severe medical condition wherein a blood clot obstructs the arteries in the lungs, potentially leading to life-threatening consequences.

PE Assist is designed to assist radiologists in identifying and communicating suspected positive findings of pulmonary embolism in chest CT angiograms. This facilitates quicker intervention, potentially saving lives.

Utilising advanced artificial intelligence algorithms, PE Assist analyses medical images, classifies thrombus into four subclasses, and provides information about the presence or absence of right heart strain.

Dr Arjun Kalyanpur, CEO and chief radiologist at Telerad Group's Teleradiology Solutions, emphasised the significance of launching PE Assist at RSNA and noted, "PE Assist is not just a technological breakthrough; it is a paradigm shift that underscores the immense potential of Indian innovation on the global stage. This game-changing solution has the power to revolutionise how we approach pulmonary embolism diagnostics, offering healthcare professionals a tool for swift identification and faster intervention."

Dr Sunita Maheshwari, cofounder and chief dreamer at Telerad Group, highlighted the significance of the 'Made in India' algorithm in revolutionising global healthcare. She added that the innovative technology presented at RSNA has the potential to impact millions of lives by addressing a crucial aspect of medical diagnostics.

In another development in the realm of imaging and diagnostics, the Telerad group entered into a Memorandum of Understanding (MoU) with Bengaluru's National Institute of Mental Health and Neurosciences (NIMHANS) to improve the diagnosis and interpretation of strokes and head injuries.

This collaboration involves Telerad Group's Telerad Tech and Telerad Foundation, alongside NIMHANS, conducting research and development jointly. Their focus is on implementing stroke protocols and using AI-enhanced radiology diagnostics.

Established in 2002, Telerad Group’s Teleradiology Solutions, headquartered in Bengaluru, offers remote radiology services, including CT scans, MRIs, x-rays, ultrasounds, nuclear medicine, and echocardiograms. The Bengaluru-based company serves over 150 hospitals in 21 countries, spanning India, the United States, Singapore, Nigeria, Tanzania, Uganda, and the Maldives.